Financhill
Back

Genmab AS Stock Predictions

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 39.7% based on the past 16 years of stock performance.
  • Genmab AS has risen higher in 10 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $21.86. The Score for GMAB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 39.7% based on the past 16 years of stock performance.

Genmab AS Stock Rating

Sell
49
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 10 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
28.56
52-Week Low:
17.24

Prediction Charts

Market Cap:
13.5B
Price in USD:
21.86
Volume:
1M
Beta:
0.69

Technical Analysis

SMA50:
21.04
SMA100:
20.82
SMA200:
21.27
52-Wk Change:
-14.97%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 21.86 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-20 21.45 21.16 21.45 21.07
Jun-23 20.89 20.68 21.02 20.64
Jun-24 20.68 20.74 20.91 20.49
Jun-25 20.53 20.52 20.60 20.31
Jun-26 20.70 20.73 20.74 20.58
Jun-27 20.59 20.50 20.75 20.39
Jun-30 20.47 20.66 20.69 20.44
Jul-1 20.49 20.74 21.08 20.46
Jul-2 20.35 20.44 20.59 20.24
Jul-3 20.42 20.30 20.44 20.23
Jul-7 20.50 20.52 20.56 20.33
Jul-8 20.84 21.25 21.41 20.79
Jul-9 21.31 21.58 21.65 21.28
Jul-10 21.68 21.86 21.90 21.53

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $5.21 per share, an increase this year of $0.22 per share, and an increase next year of $0.19 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.